131 related articles for article (PubMed ID: 10544442)
1. Sensitization following Thymoglobulin and Atgam rejection therapy as determined with a rapid enzyme-linked immunosorbent assay. US Thymoglobulin Multi-Center Study Group.
Regan JF; Campbell K; Van Smith L; Schroeder TJ; Womble D; Kano J; Buelow R
Transpl Immunol; 1999 Jun; 7(2):115-21. PubMed ID: 10544442
[TBL] [Abstract][Full Text] [Related]
2. Characterization of anti-thymoglobulin, anti-Atgam and anti-OKT3 IgG antibodies in human serum with an 11-min ELISA.
Regan J; Campbell K; van Smith L; Pouletty P; Schroeder TJ; Guttmann RD; Buelow R
Transpl Immunol; 1997 Mar; 5(1):49-56. PubMed ID: 9106335
[TBL] [Abstract][Full Text] [Related]
3. Results of the double-blind, randomized, multicenter, phase III clinical trial of Thymoglobulin versus Atgam in the treatment of acute graft rejection episodes after renal transplantation.
Gaber AO; First MR; Tesi RJ; Gaston RS; Mendez R; Mulloy LL; Light JA; Gaber LW; Squiers E; Taylor RJ; Neylan JF; Steiner RW; Knechtle S; Norman DJ; Shihab F; Basadonna G; Brennan DC; Hodge EE; Kahan BD; Kahan L; Steinberg S; Woodle ES; Chan L; Ham JM; Schroeder TJ
Transplantation; 1998 Jul; 66(1):29-37. PubMed ID: 9679818
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blinded comparison of Thymoglobulin versus Atgam for induction immunosuppressive therapy in adult renal transplant recipients.
Brennan DC; Flavin K; Lowell JA; Howard TK; Shenoy S; Burgess S; Dolan S; Kano JM; Mahon M; Schnitzler MA; Woodward R; Irish W; Singer GG
Transplantation; 1999 Apr; 67(7):1011-8. PubMed ID: 10221486
[TBL] [Abstract][Full Text] [Related]
5. Total and active thymoglobulin levels: effects of dose and sensitization on serum concentrations.
Regan JF; Lyonnais C; Campbell K; Smith LV; Buelow R;
Transpl Immunol; 2001 Oct; 9(1):29-36. PubMed ID: 11680569
[TBL] [Abstract][Full Text] [Related]
6. A prospective, randomized, double-blinded comparison of thymoglobulin versus Atgam for induction immunosuppressive therapy: 10-year results.
Hardinger KL; Rhee S; Buchanan P; Koch M; Miller B; Enkvetchakul D; Schuessler R; Schnitzler MA; Brennan DC
Transplantation; 2008 Oct; 86(7):947-52. PubMed ID: 18852661
[TBL] [Abstract][Full Text] [Related]
7. Reduced human IgG anti-ATGAM antibody formation in renal transplant recipients receiving mycophenolate mofetil.
Kimball JA; Pescovitz MD; Book BK; Norman DJ
Transplantation; 1995 Dec; 60(12):1379-83. PubMed ID: 8545860
[TBL] [Abstract][Full Text] [Related]
8. Comparison of polyclonal induction agents in pediatric renal transplantation.
Brophy PD; Thomas SE; McBryde KD; Bunchman TE
Pediatr Transplant; 2001 Jun; 5(3):174-8. PubMed ID: 11422819
[TBL] [Abstract][Full Text] [Related]
9. Comparison between thymoglobulin and ATGAM as an induction agent in adult kidney transplantation: a single-center experience.
Kim JM; Jang HR; Ko JS; Kwon CH; Kwak MS; Hur WS; Kim SJ; Kim GS; Joh JW; Lee SK; Oh HY
Transplant Proc; 2012 Jan; 44(1):171-4. PubMed ID: 22310607
[TBL] [Abstract][Full Text] [Related]
10. Thymoglobulin versus ATGAM induction therapy in pediatric kidney transplant recipients: a single-center report.
Khositseth S; Matas A; Cook ME; Gillingham KJ; Chavers BM
Transplantation; 2005 Apr; 79(8):958-63. PubMed ID: 15849550
[TBL] [Abstract][Full Text] [Related]
11. Economics of the antithymocyte globulins Thymoglobulin and Atgam in the treatment of acute renal transplant rejection.
Schnitzler MA; Woodward RS; Lowell JA; Amir L; Schroeder TJ; Singer GG; Brennan DC
Pharmacoeconomics; 2000 Mar; 17(3):287-93. PubMed ID: 10947303
[TBL] [Abstract][Full Text] [Related]
12. Cadaveric kidney transplantation under prophylactic polyclonal antibody immunosuppression with anti-lymphoblast globulin versus anti-thymocyte globulin.
Indudhara R; Novick AC; Hodge E; Goormastic M; Papajcik D; Mastroianni B; Cook D
Urology; 1996 Jun; 47(6):807-12. PubMed ID: 8677568
[TBL] [Abstract][Full Text] [Related]
13. Five-year follow up of thymoglobulin versus ATGAM induction in adult renal transplantation.
Hardinger KL; Schnitzler MA; Miller B; Lowell JA; Shenoy S; Koch MJ; Enkvetchakul D; Ceriotti C; Brennan DC
Transplantation; 2004 Jul; 78(1):136-41. PubMed ID: 15257052
[TBL] [Abstract][Full Text] [Related]
14. The US multicenter double-blind, randomized, phase III trial of thymoglobulin versus atgam in the treatment of acute graft rejection episodes following renal transplantation: rationale for study design.
Schroeder TJ; Moore LW; Gaber LW; Gaber AO; First MR
Transplant Proc; 1999 May; 31(3B Suppl):1S-6S. PubMed ID: 10330958
[TBL] [Abstract][Full Text] [Related]
15. Induction antibody therapy in renal transplantation using early steroid withdrawal: long-term results comparing anti-IL2 receptor and anti-thymocyte globulin.
Libório AB; Mendoza TR; Esmeraldo RM; Oliveira ML; Paes FJ; Silva Junior GB; Daher EF
Int Immunopharmacol; 2011 Nov; 11(11):1832-6. PubMed ID: 21835269
[TBL] [Abstract][Full Text] [Related]
16. Leukocyte response to thymoglobulin or atgam for induction immunosuppression in a randomized, double-blind clinical trial in renal transplant recipients.
Brennan DC; Flavin K; Lowell JA; Howard TK; Shenoy S; Burgess S; Dolan S; Kano JM; Mahon M; Schnitzler MA; Woodward R; Irish W; Ramachamdra V; Singer GG
Transplant Proc; 1999 May; 31(3B Suppl):16S-18S. PubMed ID: 10330962
[No Abstract] [Full Text] [Related]
17. Rapid serologic diagnosis of serum sickness from antithymocyte globulin therapy using enzyme immunoassay.
Tatum AH; Bollinger RR; Sanfilippo F
Transplantation; 1984 Dec; 38(6):582-6. PubMed ID: 6334386
[TBL] [Abstract][Full Text] [Related]
18. Serum anti-rabbit and anti-horse IgG, IgA, and IgM in kidney transplant recipients.
Prin Mathieu C; Renoult E; Kennel De March A; Béné MC; Kessler M; Faure GC
Nephrol Dial Transplant; 1997 Oct; 12(10):2133-9. PubMed ID: 9351078
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Biopsy-Proven Acute Antibody-Mediated Rejection Using Thymoglobulin (ATG) Monotherapy and a Combination of Rituximab, Intravenous Immunoglobulin, and Plasmapheresis: Lesson Learned from Primary Experience.
Zheng J; Xue W; Qing X; Jing X; Hou J; Tian X; Guo Q; He X; Cai J
Clin Transpl; 2014; ():223-30. PubMed ID: 26281149
[TBL] [Abstract][Full Text] [Related]
20. Comparison of Minnesota antilymphoblast globulin and Upjohn antithymocyte globulin for induction immunosuppression of human renal allografts.
Pescovitz MD; Book BK; Milgrom ML; Leapman SB; Petersen B; Filo RS
Surgery; 1994 Oct; 116(4):811-8. PubMed ID: 7940183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
